... inhibitors of the PI3K/Akt pathway inprostatecancer cells Combined effects of ErPC3 and ionizing radiation inprostatecancer cell lines Up to now our data revealed that ErPC3 is a potent inhibitor ... ErPC3, in preclinical and clinical investigations is based on their ability to induce apoptosis in tumor cells and their ability to increase cytotoxic efficacy of chemotherapy and radiotherapy in ... inactivated in a variety of solid human tumors, including prostatecancer Increased levels of PIP3 trigger the recruitment of phosphatidylinositide-dependent serine/threonine kinase (PDK1) and Akt...
... liver and pancreas by immunohistochemical staining In contrast, PSA was stained in both prostatecancer tissue and non-cancerous tissue (Figure 2C) These data indicated that AMACR had a mostly cancer- specific ... Immunostaining of prostatecancer tissue with antibodies against AMACR and PSA Immunostaining of prostatecancer tissue with antibodies against AMACR and PSA Surgically resected prostatecancer tissue ... was detected in three prostatecancer cell lines (LNCaP, DU145 and PC-3) C Expression of AMACR incancer tissues and noncancerous tissues from surgical specimens of two prostatecancer cases...
... of ezrin in intercalated duct cells, the tubular complexes of CP and PanINs (A) Staining of ezrin in the intercalated duct cells in the paraneoplastic tissues (B-D) Ezrin-positive staining in the ... cells, such as increased protrusions and microvilli Ezrin overexpression inducing Erk1/2 activation The results described above indicate that ezrin is involved in the motility andinvasion of MiaPaCa-2 ... lesions (n = 34) and CP (n = 28) were assessed and graded in the pancreatic tissues adjacent to the tumor in hematoxylin and eosin-stained slides Immunostaining for ezrin was performed using the primary...
... training, testing and validating the network showed curve flattening after a few training epochs, this indicated that no overtraining occurred However, if such a model is to be applied on clinical ... preclinical study inprostatecancer xenografts, and suggest that the combination of functional MRI parameters, in addition to standard clinical parameters, increases the power of predicting therapeutic ... prediction, wherein different pre-treatment and early in- treatment functional imaging parameters may be combined with standard clinical parameters in order to increase the prediction of how individual...
... becoming one of the most significant issues in treatment decision-making, in general, and more so inprostatecancer [1] Thus late rectal and urinary damage became a major concern inprostate cancer; ... radiotherapy-irradiation of prostate, seminal vesicles, and lymph nodes followed by a prostate boost (116 patients, 59%); and prostate- only (PO) radiotherapy-irradiation of prostateand seminal vesicles (81 ... volume and critical normal structure definition Treatment planning and irradiation were performed with the patients in supine position (using knee and ankle supports) with an emptied rectum and...
... several protein tyrosine- and histidine kinases [810], and inhibits topoisomerase I and II [11] These effects result in alterations of several intracellular and extracellular pathways including cell ... radiosensitivity in the androgen independent PC cell line PC-3 has been demonstrated in vitro andin vivo [26,27] Our study analyzes the interactions of irradiation and genistein or estradiol incubation in androgen ... anti -prostate cancer activity in vitro andin vivo Clin Cancer Res 2004, 10:5282-5292 Ouchi H, Ishiguro H, Ikeda N, Hori M, Kubota Y, Uemura H: Genistein induces cell growth inhibition in prostate...
... Kemmerling L, Born EJ, Mini R, Greiner RH, Aebersold DM: Daily organ tracking in intensitymodulated radiotherapy of prostatecancer using an electronic portal imaging device with a dose saving acquisition ... abdomen and pelvis and a total-body bone scan When clinically indicated a chest x-ray and/ or thoracic CT was performed Based on these examinations clinical staging was defined according to the ... summarized in Table Incidence of single symptoms (diarrhea, rectal pain, rectal bleeding) as well as the highest toxicity occurred in a given patient concluding all single symptoms but counting only...
... 23 patients) in Table and the mean standard deviations (mean random error) in Table Then, we determined means and standard deviations from control EPIs for each patient resulting in the same error ... values10%variability, prostate line), format, Measured deviations inand Measured deviations in LR, SI and AP directions in a box plot format, showing the mean values (black squares), the median values (lines in ... issue indicate that a 3mm planning target margin is in most cases sufficient to account for intrafractional motion [39] Both uncertainties, setup error and target motion can be split into random and...
... somatostatin and Octreotide inprostatecancer cell lines To examine the regulatory effects of somatostatin and Octreotide on XAF1 mRNA and protein expression, prostatecancer cell lines (LNCaP, ... somatostatin indicates a promising strategy for prostatecancer therapy Materials and methods Cell lines and cell culture A human prostate epithelial cell line (RWPE-1) andprostatecancer cell lines ... inprostatecancer cell lines We found that somatostatin and Octreotide up-regulated XAF1 mRNA and protein expression inprostatecancer cell lines The enhanced XAF1 expression by somatostatin...
... with prostatecancer invasion, metastasisand poorer survival inprostatecancer [36,37] and its value as a prognostic marker has been well established in breast cancer [38,39] We found in our ... JS: RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostatecancer cell invasion, survival, and tumorigenicity in vivo ... targeted therapeutics for prostatecancer candidate predictor of efficacy in both prostateand breast cancer Finally, the observed sensitivity to dasatinib of prostatecancer cell lines with expression...
... Occurrence of ProstateCancer (PCa) in Men 2-3 1.2 Prostateand its Importance 1.3 Signs & Symptoms and Detection of Prostate Cancers 1.4 Treatment Options for ProstateCancer 1.4.1 Hormone or Androgen ... 113 4.2.1.4.6 Standardisation via checking on β-actin 114 4.2.2 Determination of Saturating Doses of Known AKR1C3 Inhibitor and Dimethoxycurcumin and its Potential as AKR1C3 Enzyme Inhibitor 4.2.2.1 ... using non-androgenic ligands such as estrogens for activation also seemed to play a role in maintaining proliferation of these cells AKR1C3 is the critical enzyme to synthesise T and DHT in prostate...
... unit and Surveillance (WCISU) Between 1996 and 2004 the age standardised incidence rate of prostatecancer increased in all cancer networks in England and Wales1 In England the average increase ... evidence incorporating health economic evidence distilling and synthesising the evidence and writing recommendations agreeing the recommendations structuring and writing the guideline updating the ... risks (including the increased chance of having to live with the diagnosis of clinically insignificant prostate cancer) and benefits of prostate biopsy If the clinical suspicion of prostate cancer...
... used in this guideline .38 Introduction Prostatecancer is one of the most common cancers in men Every year there are 34,986 new cases in England and Wales and 10,000 deaths Prostatecancer ... (including the increased chance of having to live with the diagnosis of clinically insignificant prostate cancer) and benefits of prostate biopsy 1.2.3 If the clinical suspicion of prostatecancer ... (for example, UK Prostate Link – www .prostate- link.org.uk), local and national cancer information services, and from cancer support groups 1.1.4 Before choosing or recommending information resources...
... continuing advances in technical and professional knowledge Certain principles remain just as important in diagnosis as they are in screening Training, multidisciplinary teamwork, monitoring and ... screening should be established in line with the routine screening interval, taking into consideration that most programmes not succeed in keeping the routine screening interval for each individual ... screening should be established in line with the routine screening interval, taking into consideration that most programmes not succeed in keeping the routine screening interval for each individual...
... IntegrinsinProstateCancerInvasionandMetastasis 619 Paulynn Chin Suyin, Joanne Louise Dickinson and Adele Frances Holloway Chapter 26 The Role of E-Cadherin-Catenin Complex inProstateCancer ... of all prostatecancer cases The risk of getting prostatecancer increases nearly exponentially with increasing age This makes prostatecancer one of the most distinctive cancers in aging popu‐ ... Stovall and Guangchao Sui Chapter 24 The Role of PARP Activation inProstateCancer 589 Luis A Espinoza VII VIII Contents Section Cell Adhesion Proteins inProstateCancer 617 Chapter 25 Integrins in...
... serial reinjection into the prostate of prostatecancer cell lines or by growing Human ProstateCancer 23 Table Profile of Established Human ProstateCancerand Immortalized Cell Lines Cell line PC-93 ... carcinoma Int J Cancer 29, 611–616 Giles, G G and Ireland, P (1997) Diet, nutrition andprostatecancer Int J Cancer 74, 1–5 Smith, D P and Armstrong, B K (1998) Prostate- specific antigen testing ... human-papillomavirus infection and risk of prostatecancer Int J Cancer 75, 564–567 60 Rotkin, I D (1977) Studies in the epidemiology of prostatic cancer: expanded sampling Cancer Treatment Reports...
... produced by LNCaP -prostate cancer cell line Prostatecancer cell lines (LNCaP and DU145), as indicated, were maintained in culture as a source of positive-control prostatecancer exosomes (for ... loading Bands for prostate- derived proteins PSA or PSMA were evident in patients (p1, p7, p8, p9, p10), indicating that at least some of the exosomes present in the urine were of prostate origin ... advances are being made in understanding the biology underlying this disease, andin many respects in its treatment, there remains a need for better tools for PCa diagnosis and monitoring Disease-related...
... inprostate epithelial cell lines specifically in LNCaP cells [3,18] In addition, the prostatecancer cell line 22Rv1 has been shown to be chronically infected with XMRV and produces highly infectious ... replicate in these cells Findings This report builds on and challenges the published data on the absence of A3G protein inprostate epithelial cells lines We demonstrate the presence of A3G inprostate ... immunoblotting using anti-ApoC29 to assist in A3G identification in the gel for mass spectrometry The gel bands corresponding to A3G protein were excised and were subjected to in- gel trypsin digestion...
... TGase-4 and MDA-7/IL-24 inprostatecancer cells We have stained MDA-7 inprostatecancer cells Shown in Figure 5A, PC-3 wild type cells stained for MDA-7, mostly in the cytosolic region and perinucleus ... TGase-4 is linked to the invasiveness of prostatecancer cells [12] and participates in the regulation of the interactions between prostatecancer cells and endothelial cells, the later involving the ... co-localize in normal and malignant human prostate tissues Shown in Figure (B, C and D), strong staining of TGase-4 was seen in the matrix and epithelial cells Prostate tissues also showed staining of...